Brevan Howard Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,396	Closed	-$219K	–	1273
2024 Q4	$219K	Sell	1,396 -698	-33%	-$109K	﹤0.01%	855
2024 Q3	$381K	Buy	+2,094	New	+$381K	﹤0.01%	713
2024 Q2	–	Sell	-14,127	Closed	-$2.51M	–	1186
2024 Q1	$2.51M	Buy	+14,127	New	+$2.51M	0.02%	87